.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Hypothyroidism: Challenges in Optimal Patient Management

Todd Frieze, MD, FACP, FACE, provides an overview on hypothyroidism management and its hurdles, including a patient case and best practices for optimal care.

EP 1: Introduction: Optimizing Patient Management in Hypothyroidism

October 1st 2021

Todd Frieze, MD, FACP, FACE, introduces himself as well as the purpose of today’s presentation, which is to optimize patient management in hypothyroidism.

EP 2: Overview of Hypothyroidism

October 1st 2021

Todd Frieze, MD, FACP, FACE, provides an overview of hypothyroidism including its prevalence within the U.S., impact on thyroid function, and etiology.

EP 3: Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

October 1st 2021

Expert discusses the clinical manifestations and physiological implications of hypothyroidism, in addition to screening and diagnosis of this disease.

EP 4: Hypothyroidism: Goals, Challenges, and Special Populations

October 1st 2021

Guideline recommendations for treatment and goals of therapy in hypothyroidism, as well as challenges and special patient populations, are discussed.

EP 5: Patient Case: Hypothyroidism Diagnosis and Optimal Management

October 1st 2021

Todd Frieze, MD, FACP, FACE, walks us through a patient case revealing the importance of medication compliance and the potential impact of switching therapy.

EP 6: Hypothyroidism: Challenges in Optimal Patient Management

January 11th 2022

In this Medical Economics® “PrimaryView,” Todd Frieze, M.D., FACP, FACE, endocrinologist at the Thyroid Institute of Utah in Lehi, provides insights on hypothyroidism with an overview of the disease; an examination of the clinical manifestations, diagnosis and treatment guidelines; and a review of the importance of accurate dosing of a medication with a narrow therapeutic index (NTI) and its impact on switching therapies. This article summarizes the highlights of the presentation.